These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 14574911)
1. The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer. Ward SE; Kaltenthaler E; Cowan J; Marples M; Orr B; Seymour MT Br J Cancer; 2006 Jul; 95(1):27-34. PubMed ID: 16804526 [TBL] [Abstract][Full Text] [Related]
2. The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer. Almond J; Ralston S Br J Cancer; 2007 May; 96(9):1489; author reply 1490. PubMed ID: 17437019 [No Abstract] [Full Text] [Related]
3. Just when you thought the fluorouracil debate was over: S-1 and gastric cancer. Ilson D J Clin Oncol; 2005 Oct; 23(28):6826-8. PubMed ID: 16145059 [No Abstract] [Full Text] [Related]
4. Capecitabine and tegafur + uracil: new preparations. Metastatic colorectal cancer: two oral fluorouracil precursors, few advantages. Prescrire Int; 2002 Apr; 11(58):44-7. PubMed ID: 11987311 [TBL] [Abstract][Full Text] [Related]
5. [Intravenous continuous infusion of fluorouracil for treatment of metastatic colorectal cancer]. Hosokawa A Nihon Rinsho; 2003 Sep; 61 Suppl 7():352-5. PubMed ID: 14574911 [No Abstract] [Full Text] [Related]
6. Oral fluoropyrimidines in colorectal cancer. Van Cutsem E; Peeters M Semin Oncol; 2000 Oct; 27(5 Suppl 10):91-5. PubMed ID: 11049039 [No Abstract] [Full Text] [Related]
8. [Present status of chemotherapy for colorectal cancer in countries outside of Japan]. Doi T; Ohtsu A Nihon Rinsho; 2003 Sep; 61 Suppl 7():368-73. PubMed ID: 14574915 [No Abstract] [Full Text] [Related]
9. [Oral fluoropyrimidines in the treatment of colorectal carcinoma]. Porschen R Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S121-3. PubMed ID: 12817344 [No Abstract] [Full Text] [Related]